Skip to content

Evaluation of skin benefits of the test products

A study to evaluate the efficacy of test products in providing skin benefits like moisturization, anti-aging, exfoliation and brightening benefits among healthy female participants. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080265
Enrollment
33
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Skin All-Purpose Cream (Deep Moisturization Benefit): Frequency: twice daily (morning and evening) Method of application: The participants will take the required quantity of test produ

Sponsors

Innovantase Research and development services LLP LLP
Lead Sponsor
Devipro Wellness Private Limited
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy female subjects, as determined from a recent medical history. 2. Subjects in the age group of 35-60 years (both ages inclusive) 3. Subjects with all skin types (preferably in equal ratio). 4. Subjects with dull-looking skin. 5. Subjects who have not used retinol-based products minimum 8 weeks prior to enrollment (only for group 2). 6. Subjects with fine lines around the eyes (only for group 2) 7. Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face. 8. Subjects who agree not to use any other product/treatment/home remedy/soap bar on their face during the study period other than the test products. 9. Subjects must not be using any other skin-brightening products, or topical treatments during the study period (mandatory for group 4). 10. Subjects who agree not to carry out bleaching or any other procedures including facial etc. on face during the study period. 11. Subjects who agree not to expose to excessive sunlight. (Sun exposure not more than half an hour daily and during that time use of umbrella to cover face). 12. Subjects willing to give voluntary written informed consent and agree to come for regular follow-up.

Exclusion criteria

Exclusion criteria: 1. A known history or present condition of an allergic response to any cosmetic products. 2. Subject having active skin diseases (e.g., active atopic dermatitis, pigmented contact dermatitis or other cutaneous manifestations), which will interfere with the assessment. 3. Subjects who have sensitivity towards products containing AHA/BHA or Vit C or Retinol components. 4. Subjects had cancer in the last 10 years 5. Subjects with wounds, sunburn, scars, tattoos or piercings at the skin test site(s) 6. Subjects with application of ointments, creams etc. for antibacterial, anti-allergic or immunosuppressive treatment of the skin at the test site(s) 7. History of intense sun exposure and/ photo toxicity/allergy. 8. Female subjects who are pregnant, lactating or nursing. 9. Chronic illness which may influence the cutaneous state. 10. Subject participating in any other cosmetic or therapeutic trial. 11. Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness

Design outcomes

Primary

MeasureTime frame
1) the deep moisturization benefit between groups as well as against the baseline,using dermatological and instrumental assessments. 2) the antiaging benefit between groups as well as against the baseline,using dermatological and instrumental assessments. 3) the exfoliation benefits between groups as well as against the baseline,using dermatological and instrumental assessments. 4) the brightening effect between groups as well as against the baseline,using dermatological and instrumental assessments. Timepoint: baseline, weeks 1,2,4 and 8

Secondary

MeasureTime frame
the efficacy of test products using subject self-assessment.Timepoint: 8 weeks

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical research

ritambhara@msclinical.com08040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026